Clinical Trial Update: Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years [NA]

View source ↗

Summary

The clinical trial evaluating Echinacea as prophylaxis for upper respiratory infections in children aged 1-5 years has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• Echinacea (Echinacea)

Snippet

Sponsor: Hormozgan University of Medical Sciences | Conditions: Upper Respiratory Tract Infections | NA | Status: COMPLETED